StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19+0.00 (+1.30%)

Close on Nov 17, 2026Market cap $2.39MP/E –Yield –

20/20 Biolabs operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$1.92M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.92M–
FY2024Dec 31, 2024-$2.60M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$605.46K–
Q1 FY2026Mar 31, 2026-$1.29M–
Q2 FY2025Jun 30, 2025-$534.11K–
Q1 FY2025Mar 31, 2025-$488.29K–

More 20/20 Biolabs figures

See a number that looks wrong?